Travere Therapeutics Logo

Travere Therapeutics

🇺🇸
TVTX
US89422G1076

Travere Therapeutics is a US-based biopharmaceutical company dedicated to the development of innovative therapies for rare kidney diseases. Through cutting-edge research, the company identifies and delivers life-changing solutions to patients worldwide, addressing significant unmet medical needs.

Next Quarterly Earnings

Thursday, October 22, 2026
CW 43
After-Hours
In 56 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on September 24, 2026

Stock Price

Frequently asked questions

When will Travere Therapeutics report its next quarterly earnings?

Travere Therapeutics is scheduled to report its next quarterly earnings on 10/22/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Travere Therapeutics last report quarterly earnings?

Travere Therapeutics last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.37 USD.

How does Travere Therapeutics stock react to earnings?

Across its last 3 earnings reports, Travere Therapeutics stock moved by ±5.3% on average the following day. The largest reaction was +12% on 08/04/2026; 2 of 3 reactions were positive.

How often has Travere Therapeutics beaten expectations?

Travere Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Travere Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$0.02
Actual:
Q2 2026
Missed
Estimate:-$0.11
Actual:-$0.37
Difference:-$0.26
Price reaction (1 day):+12.0 %
Price reaction (7 days):+7.5 %
Q1 2026
Missed
Estimate:-$0.23
Actual:-$0.40
Difference:-$0.17
Price reaction (1 day):-0.2 %
Price reaction (7 days):-3.1 %
Q4 2025
Beat
Estimate:$0.00
Actual:$0.03
Difference:+$0.03
Price reaction (1 day):+3.7 %
Price reaction (7 days):+1.4 %
Q2 2025
Beat
Estimate:-$0.09
Actual:$0.59
Difference:+$0.67
Q1 2025
Beat
Estimate:$0.04
Actual:$0.13
Difference:+$0.09

Earnings statistics

Stock reaction to earnings

±5.3%
Avg. next-day move
+12%
Largest move (08/04/2026)
66.7%
Share of positive reactions
±4%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+66.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Travere Therapeutics
Ticker Symbol
TVTX
ISIN
US89422G1076
Country
🇺🇸
USA
Sector